Similar articles

• Responses of plasma concentrations of A type natriuretic peptide and B type natriuretic to alacepril, an angiotensin-converting enzyme inhibitor, in patients with congestive heart failure.

  Cheung B. Cheung B. Br Heart J. 1995 Jun;73(6):584-5. doi: 10.1136/hrt.73.6.584-b. Br Heart J. 1995. PMID: 7626365 Free PMC article. No abstract available.
• Responses of plasma concentrations of A type natriuretic peptide and B type natriuretic peptide to alacepril, an angiotensin-converting enzyme inhibitor, in patients with congestive heart failure.

  Yoshimura M, Yasue H, Tanaka H, Kikuta K, Sumida H, Kato H, Jougasaki M, Nakao K. Yoshimura M, et al. Br Heart J. 1994 Dec;72(6):528-33. doi: 10.1136/hrt.72.6.528. Br Heart J. 1994. PMID: 7857734 Free PMC article. Clinical Trial.
• Diagnosis of symptomless left ventricular dysfunction.

  Barnett DB. Barnett DB. Lancet. 1993 May 1;341(8853):1124-5. doi: 10.1016/0140-6736(93)93132-k. Lancet. 1993. PMID: 8097808 No abstract available.
• Natriuretic peptides: biochemistry, physiology, and therapeutic role in heart failure.

  Stoupakis G, Klapholz M. Stoupakis G, et al. Heart Dis. 2003 May-Jun;5(3):215-23. doi: 10.1097/01.HDX.0000074517.30102.64. Heart Dis. 2003. PMID: 12783635 Review.
• [Recommendations for the clinical use of cardiac natriuretic peptides].

  Emdin M, Clerico A, Clemenza F, Galvani M, Latini R, Masson S, Mulè P, Panteghini M, Valle R, Zaninotto M, Ganau A, Mariotti R, Volpe M, Aspromonte N, Cacciatore G, Cappelletti P, L'Abbate A, Miglio F, Ottani F, Pagani F, Passino C, Plebani M, Sarzani R, Zucchelli G. Emdin M, et al. Ital Heart J Suppl. 2005 May;6(5):308-25. Ital Heart J Suppl. 2005. PMID: 15934430 Review. Italian. No abstract available.